The up-regulation of YAP1 degradation upon elimination of USP9X enhances cellular sensitivity to chemotherapy, indicating the oncogenic role of USP9X and identifying it as a potential therapeutic target for breast cancer treatment.318. This evidence concerns the gene YAP1 and breast carcinoma.